Broker Data for the last 3 weeks has been fairly straightforward.....Run is not coming yet, retail selling and smart money accumulating. Carry on lads.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%